Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN TECHNOLOGIES

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 38

FDA approve RIVASTIGMINE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 32

FDA approve RIVASTIGMINE

Comment Full text

ACADIA PHARMS INC

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 31

FDA approve PIMAVANSERIN TARTRATE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Jan. 22, 2025, 05:09 UTC
  • 34

FDA approve ACETAMINOPHEN; IBUPROFEN

Comment Full text

NOVAST LABS

  • FDA Approval
  • Jan. 20, 2025, 09:46 UTC
  • 38

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

YICHANG HUMANWELL

  • FDA Approval
  • Jan. 20, 2025, 09:46 UTC
  • 33

FDA approve CARBAMAZEPINE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Jan. 20, 2025, 09:46 UTC
  • 37

FDA approve HALOPERIDOL LACTATE

Comment Full text

SANDOZ

  • FDA Approval
  • Jan. 20, 2025, 09:46 UTC
  • 33

FDA approve TRIFLUOPERAZINE HYDROCHLORIDE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Jan. 20, 2025, 09:46 UTC
  • 38

FDA approve TELMISARTAN

Comment Full text

SANDOZ

  • FDA Approval
  • Jan. 20, 2025, 09:46 UTC
  • 39

FDA approve TRIFLUOPERAZINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 111
  • 112
  • 113
  • 114
  • 115
  • Next

Search

News categories

  • Technical Exchange News(9551)
  • Event(407)
  • SEC News(156644)
  • FDA Approval(8944)
  • Company Report(721)
  • Business News(106282)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin